Bellicum Pharmaceuticals Announces Initiation of Phase I/II Clinical Trial of Novel Vaccine for Patients With Advanced Prostate Cancer
HOUSTON, Aug. 6 /PRNewswire/ -- Bellicum Pharmaceuticals, Inc. today announced dosing of the first patient in a Phase I/II
clinical trial of BP-GMAX-CD1, a novel pharmacologically regulated dendritic cell vaccine for the treatment of prostate cancer. The disease-specific trial is be...
Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis
THE WOODLANDS, Texas, Aug. 4 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that it has initiated a Phase 2 cli...
Journal of Clinical Oncology Publishes TREANDA Study Demonstrating Significant Improvement in Overall Response and Progression-Free Survival in Chronic Lymphocytic Leukemia
FRAZER, Pa., Aug. 3 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH ) today announced that the Journal of
Clinical Oncology has published data from a pivotal phase 3 study demonstrating that TREANDA(R) (bendamustine HCl) for Injection improved
clinical outcomes when compared to chl...
New InfoLogix M24 Mobile Clinical Assistant Will Enable Hospitals to Access Electronic Medical Records (EMR) Directly at the Point of Care
HATBORO, Pa., August 3 /PRNewswire-FirstCall/ -- InfoLogix, Inc. (Nasdaq: IFLG ), a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, announced today the introduction of a new mobility offering for healthcare providers, the I...
Addario Lung Cancer Medical Institute Announces Diagnostic Screening and Clinical Research Collaborations With Response Genetics, Inc.
SAN FRANCISCO, July 31 /PRNewswire-USNewswire/ -- The Addario Lung Cancer Medical Institute (ALCMI) today announced the execution of a letter of intent (LOI) to collaborate with Response Genetics, Inc. (Nasdaq: RGDX ) on molecular diagnostic testing and banking of advanced-stage Lung...
Are imaging features of hepatic angiomyolipoma related to its clinical setting?
This study consisted of 10 patients (three male and seven female) with hepatic angiomyolipoma, with a mean age of 55.1 years (age range, 19-78 years). Of these patients, dynamic contrast CT showed hepatic angiomyolipoma as a hypervascular mass with intratumoral fatty density, absence of a capsule,...
Summa Health System Creates Quick Win With Their Caregiver Community By Implementing Sentillion's Clinical Workstation Solution
ANDOVER, Mass., July 30 /PRNewswire/ -- Summa Health System, a major healthcare network that serves a five county region in northeast Ohio, has gone live with Sentillion's single sign-on (SSO) and context management solutions and is systematically rolling it out to more than 4,000 caregi...
ULURU Inc. to Present Altrazeal(TM) Clinical Evidence at the American Podiatric Medical Association (APMA) Annual Scientific Meeting in Toronto, Canada
ADDISON, Texas, July 29, /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) announced today that the application of Altrazeal(TM) and best
clinical practice will be demonstrated in a hands-on Wound Care Pre Conference Workshop at the APMA Annual Scientific Meeting July 2...
Sunshine Heart Provides C-Pulse U.S. Clinical Update
SYDNEY, July 28 /PRNewswire/ -- Sunshine Heart (ASX: SHC), a global medical device company focused on innovative heart assist technologies, announced today that the first two patients implanted with the C-Pulse device in April 2009 at The Ohio State University Medical Center ...
QLT announces interim data from a Phase II clinical trial and a device study for the Punctal Plug Drug Delivery System
VANCOUVER, July 28 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI ; TSX: QLT) ("QLT" or the "Company") today announced encouraging interim data from an ongoing Phase II
clinical trial and a device study for the punctal plug delivery system. These studies are part of a development program that i...
Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results
THE WOODLANDS, Texas, July 28 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today updated its drug development progress and reported fin...
Alexza to Announce 2009 Second Quarter Financial Results and Update Its Clinical Pipeline Status on Wednesday, August 5, 2009
MOUNTAIN VIEW, Calif., July 27 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that it will release results for its second fiscal quarter ended June 30, 2009, on Wednesday, August 5, 2009, following the close of the U.S. financial market...
Male Fertility Supplement Improves Sperm Quality & Motility in Clinical Study
A
clinical study for the male fertility supplement, FertilAid for Men, was recently presented at the American Society of Andrology's annual meeting. Study results showed marked improvement in sperm parameters, particularly with respect to the overall number of normally shaped, motile sperm in the...
Lutonix, Inc. Announces First Patient Enrollments in Three Separate Clinical Trials
MINNEAPOLIS, July 27 /PRNewswire/ -- Lutonix, Inc., a privately held medical device start-up, today announced that patient enrollment is underway for its three simultaneous first-in-human
clinical trials. The three studies are designed to test whether the proprietary Lutonix Drug C...
Cardiorobotics Closes $11.6M Series A Financing to Advance Clinical Development of Snake Robot for Surgery
PITTSBURGH, July 24 /PRNewswire/ -- Cardiorobotics, Inc., a medical device company developing snake robot technologies for use in a wide range of surgical and interventional applications has closed on an $11.6 Million private equity Series A round of financing. The round was led by Eagle Vent...
Six DaVita Clinics in Colorado Receive Silver Award for Clinical Excellence
DENVER, July 24 /PRNewswire-FirstCall/ -- DaVita Inc. (NYSE: DVA ), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced six of its dialysis facilities in Colorado have received the 2009 End Stage Renal Disease (ESR...
SNM's Clinical Trials Network expands European membership of PET biomarker manufacturers
Reston, Va.SNM's
Clinical Trials Network today announced that several leading commercial providers of PET radiopharmaceuticals in Europe have registered their manufacturing sites with the network. SNM's
Clinical Trials Network is an initiative designed to address the need for streamlined drug disc...
Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi3 Clinical Trial of R788 in Rheumatoid Arthritis
SOUTH SAN FRANCISCO, Calif., July 23 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced that the Company plans to host a conference call on Thursday, July 23, 2009 at 7:00 pm EDT (4:00 pm PDT). Members of Rigel's senior management team and the p...
World's First Cardiac Adult Stem Cell Patient and Physicians Discuss Clinical Trial
Infusion Procedure Performed on July 17th
LOUISVILLE, Ky., July 23 /PRNewswire-USNewswire/ -- University of Louisville physicians performed the world's first cardiac adult stem cell infusion procedure at Jewish Hospital in Louisville, KY, on July 17, 2009. The procedure i...
Glenmark Brings to the Notice of the Authorities Irregularities of the Clinical Investigator at its Jamnagar Site in Gujarat
MUMBAI, July 23 /PRNewswire-FirstCall/ --
- A Police Complaint has Been Lodged by Hospital Authorities Citing
Fraudulent Activity by the
Clinical Investigator Dr. A Bhattacharya Working
at the GG Hospital and the MP Shah Medical College
- Glenmark Not Only Acts as the Whistle-Blo...
NIAID set to launch clinical trials to test 2009 H1N1 influenza vaccine candidates
Scientists in a network of medical research institutions across the United States are set to begin a series of
clinical trials to gather critical data about influenza vaccines, including two candidate H1N1 flu vaccines. The research will be under the direction of the National Institute of Allergy ...
Ortho Clinical Diagnostics Launches 24-Hour Remote Monitoring Center
RARITAN, N.J., July 21 /PRNewswire/ -- Ortho
Clinical Diagnostics today announced the launch of its Remote Monitoring Center, the first 24-7 central command center in the in vitro diagnostic industry that continuously tracks the condition of laboratory instrument performance....
Waters Drives Efficiency in the Clinical and Research Laboratory and Showcases New MassTrak Systems at AACC 2009
CHICAGO, July 20 /PRNewswire-FirstCall/ -- At this year's American Association for
Clinical Chemistry (AACC) meeting, Waters Corporation (NYSE: WAT ) is introducing
clinical scientists to its expanded portfolio of new products for
clinical and research laboratories including ...
Quest Diagnostics MedPlus Subsidiary Enables New York Clinical Information Exchange (NYCLIX) to Share Meaningful Data and Enhance Patient Care
Patient-Based Record Improves Quality, Safety and Efficiency
MADISON, N.J., July 20 /PRNewswire-FirstCall/ -- MedPlus, the healthcare information technology subsidiary of Quest Diagnostics Incorporated (NYSE: DGX ), today announced that NYCLIX is now sharing key patient...
New HIV Study Shows That Large Numbers of Women and People of Color Can Be Successfully Enrolled In U.S. HIV Clinical Studies
BRIDGEWATER, N.J., July 20 /PRNewswire/ -- Data from a historic HIV study demonstrate that it is possible to recruit large numbers of women, African Americans and Latinos into U.S.-based HIV-1 treatment studies. The study, known as GRACE, is the largest study to date in treatment-experi...
American Society for Clinical Pathology Joins the National Healthcare Career Network
Medical society joins growing network of healthcare associations to address high workforce shortage of lab professionals
Washington DC (PRWEB) July 17, 2009 -- The American Society for
Clinical Pathology (ASCP), a 130,000-member non-profit professional medical society b...
Coming Clean About The Cleaner - Phoenix House's Chief Clinical Officer David Deitch on Intervention, and the Recovery Process That Follows
NEW YORK and LOS ANGELES, July 16 /PRNewswire/ -- "Back for a second season is A&E's hit series The Cleaner , with Benjamin Bratt starring as an 'extreme interventionist,' a character based on the life of the show's co-executive producer Warren Boyd. What's encouraging about The Clean...
Northwestern Memorial Among America's Best Hospitals in 11 Clinical Specialties According to U.S. News' 2009 Rankings
The hospital is the highest-rated Illinois hospital in six
clinical areas
CHICAGO, July 16 /PRNewswire-USNewswire/ -- Northwestern Memorial Hospital is rated in 11
clinical specialties -- six of which make it the highest ranked in Illinois -- as part of U.S. News ...
CNCB Post Graduate Studies in Clinical Nutrition (PGSCN) Program is Now Available Online
Go to www.cncb.org for more information or call 972-250-2829
DALLAS, July 15 /PRNewswire-USNewswire/ -- The following information on the CNCB Post Graduate Studies in
Clinical Nutrition (PGSCN) Program was released today by the
Clinical Nutrition Certification Board:
...
DaVita Clinical Research Appoints Mahesh Krishnan as Vice President
DENVER, July 13 /PRNewswire-FirstCall/ -- DaVita Inc. (NYSE: DVA ), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced Mahesh Krishnan, MD, MPH has been appointed to DaVita
Clinical Research(R) as Vice President for Re...
Promising hematologists begin year-long program to pursue careers in clinical research
(WASHINGTON, July 13, 2009) Twenty hematology and hematology/oncology fellows and junior faculty will begin a unique year-long education and mentoring program this summer as part of the American Society of Hematology (ASH)
Clinical Research Training Institute.
The ASH
Clinical Research Trainin...
2009 recipient of minority scholar award begins clinical research on leukemia
(WASHINGTON, July 13, 2009) Alejandro Gutierrez, MD, is the third recipient of the ASH-AMFDP grant, an award designed to help increase the number of underrepresented minority scholars in the field of hematology, and will begin his research into the pathogenesis of T-cell acute lymphoblastic leuke...
Patient Enrollment Complete for Phase I/II Clinical Trial for GALNS for Morquio A Syndrome
NOVATO, Calif., July 13 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) announced today that patient enrollment has been completed for the Phase I/II
clinical trial for BMN-110 or N-acetylgalactosamine 6-sulfatase (GALNS), intended for the treatment of the ly...
Analysis of Four Large Post-Marketing Surveillance Studies Describe Clinical Effects of Sucrose-Formulated Recombinant Factor VIII
BOSTON, July 13 /PRNewswire/ -- New data pooled from four large, "real world" post-marketing surveillance studies showed that sucrose-formulated recombinant factor VIII (rFVIII-FS) reduced bleeding and provided data regarding adverse events in more than 950 patients with mild-to-severe hemophilia ...
Three New Studies Give Clear Guidance on How to Better Recruit Volunteers for Alzheimer's Clinical Studies
- Overcoming the Biggest Obstacle to Improving Alzheimer's Treatments -
VIENNA, Austria, July 12 /PRNewswire/ -- Partnering with local physicians, working with local clinics, and conducting educational seminars and health fairs were found to be the most effective tools in recr...
Transdel Pharmaceuticals Completes Enrollment in Phase 3 Clinical Study for Novel Topical Pain Treatment
LA JOLLA, Calif., July 8 /PRNewswire-FirstCall/ -- Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP) a specialty pharmaceutical company focused on developing non-invasive, topically administered products, today announced they have successfully completed the enrollment of patients in their ...
Can a Contact Lens Cure Nearsightedness? Five-Year Clinical Study Testing Corneal Reshaping Therapy as Possible Method to Arrest Myopia
Researchers have reported positive first-year results from a
clinical trial that is testing whether specialized contact lenses can slow or halt the progression of near sightedness in children. Co principal investigators Drs S. Barry Eiden and Robert Davis, working with EyeVis Eye and Vision Resea...
ERT Launches New Online Gateway to Improve Cardiac Safety in Clinical Trials
PHILADELPHIA, July 7 /PRNewswire-FirstCall/ -- ERT (Nasdaq: ERES ), a leading provider of centralized ECG, ePRO, eClinical technology and other services to the biopharmaceutical, medical device and related industries, announced today the launch of a unique online web interface - My Study Portal(...
Mindray to Attend the 2009 American Association for Clinical Chemistry Conference
SHENZHEN, China, July 1 /PRNewswire-Asia-FirstCall/ -- Mindray Medical
International Limited (NYSE: MR ), a leading developer, manufacturer and
marketer of medical devices worldwide, today announced it will attend the 2009
American Association for
Clinical Chemistry (AACC) conference in Chic...
Hard To Treat Diseases (HTDS) Clinical Trial Update on Therapeutic effects of Combined Treatment With Ribavirin And Tiazofurin
BELGRADE, SERBIA, July 1 /PRNewswire-FirstCall/ - Hard To Treat Diseases (HTDS) ( www.htdsmedical.com ) Chief Scientist with its Slavica BioChem subsidiary, Dr. Sanja Pekovic provided updates on recent
clinical trials with animal subjects in regards to the use of Ribavirin And Tiazofurin for the p...